# Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND)

> **NCT05670353** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Sao Paulo** · enrollment: 50 (actual)

## Conditions studied

- Endometriosis
- Pelvic Pain

## Interventions

- **DRUG:** Cannabis Derivatives
- **DRUG:** Placebo
- **DRUG:** Hormonal Contraceptive Agents

## Key facts

- **NCT ID:** NCT05670353
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-01-03
- **Primary completion:** 2024-09-12
- **Final completion:** 2024-11-20
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** The study was prematurely terminated due to the results of the interim analysis conducted, as outlined in the initial project plan.
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05670353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05670353, "Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05670353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*